Telefon:
+49 (0)241 95 163 153
Fax:
+49 (0)241 95 163 155
E-Mail:
orders@antikoerper-online.de

cDNA Sequence AF251705 (AF251705) Antikörper (PE)

Dieser Maus Monoklonal Antikörper erkennt spezifisch in FACS. Er zeigt eine Reaktivität gegenüber Human.
Produktnummer ABIN2663841

Kurzübersicht für cDNA Sequence AF251705 (AF251705) Antikörper (PE) (ABIN2663841)

Target

cDNA Sequence AF251705 (AF251705)

Reaktivität

Human

Wirt

  • 1
Maus

Klonalität

  • 1
Monoklonal

Konjugat

  • 1
PE

Applikation

Flow Cytometry (FACS)

Klon

TX45
  • Aufreinigung

    The antibody was purified by affinity chromatography, and conjugated with PE under optimal conditions. The solution is free of unconjugated PE and unconjugated antibody.

    Isotyp

    IgG1 kappa
  • Applikationshinweise

    Optimal working dilution should be determined by the investigator.

    Beschränkungen

    Nur für Forschungszwecke einsetzbar
  • Buffer

    Phosphate-buffered solution, pH 7.2, containing 0.09 % sodium azide and 0.2 % (w/v) BSA .

    Konservierungsmittel

    Sodium azide

    Vorsichtsmaßnahmen

    This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

    Handhabung

    Protect from prolonged exposure to light. Do not freeze.

    Lagerung

    4 °C

    Informationen zur Lagerung

    The antibody solution should be stored undiluted between 2°C and 8°C.
  • Target

    cDNA Sequence AF251705 (AF251705)

    Andere Bezeichnung

    MAIR-II

    Hintergrund

    MAIR-II, myeloid-associated immunoglobulin-like receptor II, is the member 7 of Ig superfamily (IgSF7), also known as LMIR-II, CMRF-35 like molecule 4 (CLM-4), DIgR1, and CD300d. This transmembrane protein is expressed on monocytes/macrophages, granulocytes, mast cells, dendritic cells and some B cells. It is an activating immune receptor associated ITAM-bearing adapter DAP12 and FcRγ chain on macrophages. MAIR-II regulates myeloid cell activation and promotes secretion of cytokines and chemokines
Sie sind hier:
Chat with us!